Navigation Links
Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
Date:3/11/2008

First-of-its kind, RFID-enabled system addresses complex issues associated

with the utilization of contrast media

WAYNE, N.J., March 11 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc., a leader in diagnostic imaging, unveiled plans to launch VistaTrak(TM), an innovative contrast media management system that provides radiology departments with a new and powerful management tool to help enhance patient care and safety, optimize inventory management and improve billing accuracy.

VistaTrak is a collaboration between Bayer HealthCare Pharmaceuticals and Mobile Aspects, an industry leader in providing Radio Frequency Identification (RFID)-enabled solutions for healthcare and hospital environments. The companies worked together to optimize Mobile Aspects' proprietary iRIS(TM) platform for the unique needs and requirements of the radiology environment. Bayer is the first company to offer a contrast media management system based on an RFID platform to automate manual processes and capture valuable operational data that currently cannot be found in any one system.

The VistaTrak contrast media management system was previewed at the 2007 Radiological Society of North America (RSNA) 93rd Scientific Assembly and Annual Meeting last November, where it was well-received. The system combines RFID technology of "tagged" bottles of contrast agent with a "smart" cabinet and a specially designed interface to capture, store and manage product utilization data easily and reliably while helping to reduce the risk of human error. It helps radiology departments and administrators by providing radiology-specific solutions for the use of contrast media, such as:

-- Facilitating patient safety by automatically screening data from a

patient's electronic medical record (EMR) for, among other things,

contraindications and prior adverse events

-- Capturing important information stored on the tag, such as NDC number,

expiration date and lot number, automatically and in an efficient

manner that supports compliance with accrediting organization

requirements

-- Providing accurate contrast dosing information to improve billing

accuracy and help address any existing issues with reimbursement or

audits

-- Tracking inventory to enable departments to order and manage inventory

more efficiently and reduce waste

VistaTrak features an easy-to-use, touch-screen interface and is available in two different sizes to address varying usage needs.

"Our new, cutting-edge VistaTrak system addresses some of the most pressing concerns confronting radiology departments today, such as patient safety and the increasing requirements by accrediting organizations on the storage, handling and use of contrast media," said Douglas Stefanelli, Vice President and General Manager, Diagnostic Imaging, Bayer HealthCare Pharmaceuticals. "This is the first time RFID technology is being employed in this unique way in the radiology suite, and is an example of how Bayer HealthCare continues to innovate in radiology and helps improve patient care."

"Collaborating with Bayer HealthCare Pharmaceuticals to help address challenges in the radiology setting has provided us with another opportunity to showcase the versatility and benefits of our advanced and patented RFID- based systems in a hospital and healthcare environment," said Suneil Mandava, President and Chief Executive Officer, Mobile Aspects. "Mobile Aspects is looking forward to working with Bayer in supporting VistaTrak and its ability to help radiology departments more effectively manage risk and potentially improve the business processes in all departments that touch contrast media."

About Bayer HealthCare Pharmaceuticals

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals unit of Bayer HealthCare LLC, a division of Bayer AG. One of the world's leading, innovative companies in the healthcare and medical products industry, Bayer HealthCare combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. In the United States, Bayer HealthCare Pharmaceuticals comprises the following business units: Women's Healthcare, Diagnostic Imaging, Specialized Therapeutics, Hematology/Cardiology and Oncology. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

About Mobile Aspects

Mobile Aspects, Inc. of Pittsburgh, Pa., is a healthcare technology supplier focused on providing an integrated suite of clinical resource management solutions to automate the management of supply, asset, drug and patient tracking through the One System of CARE solution. The cornerstone of these technological capabilities is Intelligent Radio Frequency Inventory System (iRIS(TM)), the industry's leading patent-protected tracking architecture that leverages radio frequency identification (RFID) technology. Through this innovative technology, clinicians and other care providers experience a hands free approach to managing the resources used in the patient care process.

This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities and Exchange Commission (including Form 20-F). The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.


'/>"/>
SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx
2. Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement
3. Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R)
4. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
5. Bayer CropSciences Vegetable Seed Business Nunhems Acquires US Lettuce Seed Company Paragon Seed
6. Beckman Coulter to Present at the 2008 Bear Stearns London Healthcare Conference
7. Elsevier Acquires Windhover Information Inc., a Healthcare Business Intelligence Company
8. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference
9. BD to Present at Investor Healthcare Conferences
10. Abbott to Present at Lehman Brothers Healthcare Conference
11. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Susquehanna Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire-USNewswire/ ... treatments for congestive heart failure and type 2 ... license for a novel adeno-associated virus (AAV) vector ... Kay , M.D., Ph.D., at Stanford University. The ... of its paracrine gene therapy product pipeline. ...
(Date:12/8/2016)... England , December 8, 2016 ... das Unternehmen für Molekulargenetik, erweitert seine Palette an ... myPanel™ NGS Custom FH Panels, das ein schnelles ... (FH) ermöglicht. Das Panel bietet eine Erkennung von ... Variations (CNV) mit einem einzigen kleinen Panel und ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. This ... products engineered to radically streamline culture processes, minimize processing time, significantly decrease ...
(Date:12/8/2016)... Dec. 8, 2016 Soligenix, Inc. (OTCQB: SNGX) ... on developing and commercializing products to treat rare diseases ... that it will be hosting an Investor Webcast Event ... the origins of innate defense regulators (IDRs) as a ... oral mucositis and the recently announced and published Phase ...
Breaking Biology Technology:
(Date:11/28/2016)... "The biometric system market ... The biometric system market is in the growth stage ... future. The biometric system market is expected to be ... CAGR of 16.79% between 2016 and 2022. Government initiative ... in smartphones, rising use of biometric technology in financial ...
(Date:11/19/2016)... 18, 2016 Securus Technologies, a leading provider ... safety, investigation, corrections and monitoring, announced today that it ... to have an independent technology judge determine who has ... high tech/sophisticated telephone calling platform, and the best customer ... do most of what we do – which clearly ...
(Date:11/15/2016)... -- Research and Markets has announced the addition of ... to their offering. ... The global bioinformatics ... USD 6.21 Billion in 2016, growing at a CAGR of 21.1% ... market is driven by the growing demand for nucleic acid and ...
Breaking Biology News(10 mins):